Press Release:
Epilepsy Pipeline 2010 San Francisco
Visualase Inc. Selected to Present at Epilepsy Conference Highlighting New and Promising Epilepsy Therapies. Epilepsy Pipeline Update 2010 to Take Place February 25-26 in San Francisco.
Posts Tagged ‘ablation’
Former Graduate Student and Current Assistant Professor in the Department of Imaging Physics at UTMDACC, Dr. R. Jason Stafford is highlighted in The Messenger. (Reprinted with permissions from The Messenger, The University of Texas M. D. Anderson Cancer Center)
Thursday, April 2, 2009
By Sarah Petrie
Above, from left: Kamran Ahrar, M.D., and R. Jason Stafford, Ph.D., discuss an upcoming spinal surgery that will use the Visualase technology. They’ll be able to watch the tumor (ablate) in near real time during the procedure. Depending on where the tumor is located, the patient may or may not be awake during the procedure.
History books show that surgeons began removing cancerous tumors as early as the second century. Zoom ahead to 2009, take away the scalpels, scars and side effects that typically accompany surgery, and trade them for a tiny laser beam… It sounds like science fiction, but our researchers and clinicians are among the first in the nation to investigate a new procedure that does just this … and more.
Houston, Texas October 6, 2009. The U.S. FDA granted 510(k) clearance (K092197) for the PhoTex30 Diode Laser Series, Model 980nm, 810nm, 940nm. The PhoTex30 Diode Laser Series, distributed by Visualase, Inc. received broad clearance for use in surgical applications requiring ablation and coagulation of soft tissue including general surgery, urology, neurosurgery, and other surgical specialties.
FDA grants clearance for the Visualase System
Houston, Texas March 1st, 2006 The U.S. FDA granted 510(k) clearance (K053087) for the Visualase Cooled Laser Applicator System. The Visualase Cooled Laser Applicator System, manufactured by BioTex, Inc. and to be distributed by Visualase, Inc. received clearance for marketing with broad use in a number of medical specialties. “This family of products consists of a number of novel advancements in laser applicator systems,” stated Dr. Ashok Gowda, President and CEO of Visualase. “The laser diffusing fiber and cooling catheter system can be used together to allow use of higher laser powers and faster ablation times, while minimizing risk of applicator damage and tissue carbonization,” he added.
FDA Statement